Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-acetylglucosaminyltransferase III expression in lower eukaryotes

N-acetylglucosaminyltransferase III expression in lower eukaryotes

US Patent 8445227 · Granted May 21, 2013

Estimated economic value: $71,313,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies that bind CD277 and uses thereof2025
Polyspecificity reagents, methods for their preparation and use2024
Surface display of whole antibodies in eukaryotes2024
Surface display of whole antibodies in eukaryotes2024
Agonist antibodies that bind human CD137 and uses thereof2023
Glycan-based antibody-drug conjugates2022
Surface display of whole antibodies in eukaryotes2021
Surface display of whole antibodies in eukaryotes2021
Rationally designed, synthetic antibody libraries and uses therefor2021
Rationally designed, synthetic antibody libraries and uses therefor2021
Polyspecificity reagents, methods for their preparation and use2021
Methods for purifying heterodimeric multispecific antibodies from parental homod2020